Jan L. van Delft

46 papers receiving 659 citations

Peers

Jan L. van Delft
Comparison fields: 5 of 85
  • Ophthalmology 383
  • Radiology, Nuclear Medicine and Imaging 167
  • Biomedical Engineering 134
  • Molecular Biology 133
  • Immunology 99
Replace N. A. Rao with:
N. A. Rao United States
Mitan Gokulgandhi United States
M. De Saint Jean France
Ana Serrano‐Puebla Spain
Yuko Iwasaki Japan
Eiichi Shirasawa Japan
Kasper Runager Denmark
Zhenzhen Zhang China
Hanming Wang China
Marie Goldschild France
Jan L. van Delft relative to N. A. Rao United States N. A. Rao's profile →
Citations per field
00.5×10×13.4×
N. A. Rao · 1×
Citations per year

Countries citing papers authored by Jan L. van Delft

Since Specialization
Citations

This map shows the geographic impact of Jan L. van Delft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan L. van Delft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan L. van Delft more than expected).

Fields of papers citing papers by Jan L. van Delft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan L. van Delft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan L. van Delft. The network helps show where Jan L. van Delft may publish in the future.

Co-authorship network of co-authors of Jan L. van Delft

This figure shows the co-authorship network connecting the top 25 collaborators of Jan L. van Delft. A scholar is included among the top collaborators of Jan L. van Delft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan L. van Delft. Jan L. van Delft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 17
3 14
4 76
5 29
6 12
7 2
8 11
9 6
10 2
11 31
12 6
13
The effects of ultrasonically induced hyperthermia on experimental tumors in the rabbit eye.
23
14 16
15 1
16 27
17 17
18 6
19 10
20 5

About Jan L. van Delft

Jan L. van Delft is a scholar working on Ophthalmology, Biochemistry and Immunology and Allergy, having authored 47 papers that have together received 700 indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (15 papers), Ocular Oncology and Treatments (9 papers) and Inflammatory mediators and NSAID effects (8 papers). The work is most often cited by research in Ophthalmology (383 citations), Radiology, Nuclear Medicine and Imaging (167 citations) and Pharmacology (84 citations). Jan L. van Delft has collaborated with scholars based in Netherlands, Germany and France. Frequent co-authors include D. de Wolff–Rouendaal, J.A. Oosterhuis, N.J. van Haeringen, R. J. W. De Keizer, Martine J. Jager, J A van Best, E. Glasius, Itte de Waard‐Siebinga, Bettina E. Hansen and Carina G. J. M. Hilders. Their work appears in journals such as Biochemical and Biophysical Research Communications, European Journal of Pharmacology and Radiation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026